High Tower Advisors, LLC Tyme Technologies, Inc. Put Options Transaction History

High Tower Advisors, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2021 Feb 10, 2022	SELL	$0.6 - $1.04 $15,420 - $26,728	-25,700 Reduced 98.85%	300 $1,000
Q3 2021 Nov 12, 2021	BUY	$0.99 - $1.38 $25,740 - $35,880	26,000 New	26,000 $7,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.